Acute Liver Failure: An Uncommon Complication of Commonly Used Medication

被引：3
作者：
Bawany, Muhammad Z. [1 ]
Bhutto, Burhan [2 ]
Youssef, Wael I. [1 ,3 ]
Nawras, Ali [1 ,3 ]
Sodeman, Thomas [1 ,3 ]
机构：
[1] Univ Toledo, Dept Internal Med, Med Ctr, Toledo, OH 43614 USA
[2] King Abdul Aziz Med Ctr, Riyadh, Saudi Arabia
[3] Univ Toledo, Dept Gastroenterol & Hepatol, Med Ctr, Toledo, OH 43614 USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2013年 / 20卷 / 05期
关键词：
acute liver injury; hepatitis; drug-induced liver injury; FULMINANT HEPATIC-FAILURE; HEPATOTOXICITY; INJURY;
D O I：
10.1097/MJT.0b013e3182192d5a
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The incidence of drug-related acute liver failure is approximately 14 per 100,000 populations. Drug-induced liver injury may take place through a variety of mechanism. Withdrawal of the offending agent may result in complete recovery. Clindamycin is known to cause mild derangement of liver function; however, acute liver injury causing severe derangement of liver function associated with encephalopathy is uncommon.
引用
收藏
页码：566 / 568
页数：3
相关论文
共 12 条
  • [1] Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period
    Andrade, RJ
    Lucena, MI
    Fernández, MC
    Pelaez, G
    Pachkoria, K
    García-Ruiz, E
    García-Munoz, B
    González-Grande, R
    Pizarro, A
    Durán, JA
    Jiménez, M
    Rodrigo, L
    Romero-Gomez, M
    Navarro, JM
    Planas, R
    Costa, J
    Borras, A
    Soler, A
    Salmerón, J
    Martin-Vivaldi, R
    [J]. GASTROENTEROLOGY, 2005, 129 (02) : 512 - 521
  • [2] Clindamycin-induced acute cholestatic hepatitis
    Ayguen, Cem
    Kocaman, Orhan
    Guerbuez, Yesim
    Sentuerk, Omer
    Huelague, Sadettin
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (40) : 5408 - 5410
  • [3] The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice
    Bjornsson, Einar
    Davidsdottir, Loa
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 (03) : 511 - 517
  • [4] Review article: drug hepatotoxicity
    Chang, C. Y.
    Schiano, T. D.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (10) : 1135 - 1151
  • [5] Ellis AJ, 1996, HEPATOLOGY, V24, P1446, DOI 10.1002/hep.510240625
  • [6] FULMINANT HEPATIC-FAILURE - SUMMARY OF A WORKSHOP
    HOOFNAGLE, JH
    CARITHERS, RL
    SHAPIRO, C
    ASCHER, N
    [J]. HEPATOLOGY, 1995, 21 (01) : 240 - 252
  • [7] Medical progress: Drug-induced hepatotoxicity
    Lee, WM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05) : 474 - 485
  • [8] LIDOFSKY SD, 1993, GASTROENTEROL CLIN N, V22, P257
  • [9] MUNOZ SJ, 1993, SEMIN LIVER DIS, V13, P395
  • [10] EARLY INDICATORS OF PROGNOSIS IN FULMINANT HEPATIC-FAILURE
    OGRADY, JG
    ALEXANDER, GJM
    HAYLLAR, KM
    WILLIAMS, R
    [J]. GASTROENTEROLOGY, 1989, 97 (02) : 439 - 445
12